BRO Investors – A Brief Stock Analysis

By Ken Smith • Thursday, July 17 10:04 • Permanent Link

Brown & Brown logged a -0.4% change during today's morning session, and is now trading at a price of $104.5 per share. The S&P 500 index moved 0.0%. BRO's trading volume is 246,912 compared to the stock's average volume of 3,091,783.

Brown & Brown trades -12.26% away from its average analyst target price of $119.1 per share. The 11 analysts following the stock have set target prices ranging from $102.0 to $130.0, and on average have given Brown & Brown a rating of buy.

If you are considering an investment in BRO, you'll want to know the following:

Brown & Brown's current price is 147.3% above its Graham number of $42.25, which implies that at its current valuation it does not offer a margin of safety
Brown & Brown has moved 15.7% over the last year, and the S&P 500 logged a change of 10.6%
Based on its trailing earnings per share of 3.59, Brown & Brown has a trailing 12 month Price to Earnings (P/E) ratio of 29.1 while the S&P 500 average is 29.3
BRO has a forward P/E ratio of 25.6 based on its forward 12 month price to earnings (EPS) of $4.09 per share
Its Price to Book (P/B) ratio is 4.4 compared to its sector average of 1.78
Brown & Brown, Inc. markets and sells insurance products and services in the United States, Canada, Ireland, the United Kingdom, and internationally.
Based in Daytona Beach, the company has 17,403 full time employees and a market cap of $34.47 Billion. Brown & Brown currently returns an annual dividend yield of 0.5%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.